PA-PENNENGINEERING
PennEngineering® a global leader in innovative fastening solutions, has announced the expansion of its operations located in Galway City, Ireland.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240722804353/en/
(Photo: Business Wire)
This significant extension is set to create 70 new jobs over the next five years, in support of the company's commitment to growth and community development.
The €14 million expansion project, which involves the construction of a new building, includes a state-of-the-art technology and training centre as well as testing laboratories and customer experience centre that will enhance PennEngineering’s capacity to meet the increasing demand for engineering fastening solutions. The new jobs created will span a variety of roles, including manufacturing, engineering, training and more, offering diverse opportunities for local talent.
The expansion project is supported by the Irish Government through IDA Ireland.
Minister of State for Trade Promotion, Digital and Company Regulation, Dara Calleary TD said: “I am pleased to welcome this announcement from PennEngineering which will see the creation of 70 jobs as part of a major expansion project. Investments such as this continue to advance Galway’s position, in particular, as a global hub. I am pleased to welcome this announcement and wish PennEngineering every success.”
“We are thrilled to expand our operations in Galway,” said Mary Ann Fleming, President, PennEngineering Europe. “This investment reflects our confidence in the potential for growth in the region and our commitment to contributing to the local economy. We look forward to welcoming new members to our team and continuing to innovate in the world of fastening technology. Our on-site manufacturing also continues to expand with the introduction of new products, continuing our 82-year history of product innovation in self-clinch fasteners. Supporting training and development of our people and job creation are priorities for us, and this expansion is key to this initiative. As part of this growth announcement, we welcome the board of PennEngineering on site for their biannual meeting and wish them well as they strategise for the future of our global company.”
“Our long-standing partnership with Ireland and the IDA spans over 20 years, and their support has been invaluable in fostering the growth and development of our business in Europe,” according to Pete George, PennEngineering CEO.
The expansion is expected to be completed by January 2025. PennEngineering plans to begin the recruitment process immediately, with job openings to be posted on the company’s website and local job boards.
Mary Buckley, Executive Director of IDA Ireland, said: “PennEngineering has been in Galway since 2001, and this announcement today highlights their ongoing commitment to the West Region. The operation is already a recognised centre of excellence within the global organisation and this 4000m² expansion and 70 jobs further enhances its strategic capabilities in Galway. I wish the PennEngineering team continued success.”
For more information about the expansion and job opportunities, please visit www.pemnet.com/eu/.
About PennEngineering: https://www.penn-eng.com/
Since 1942, PennEngineering® has enjoyed a sustained reputation as the global leader in the fastening industry. The company's brands, PEM®, PROFIL®, Sherex®, PennAuto®, are considered the premier manufacturer for self clinching and other mechanically attached fasteners. Haeger®, for installation systems and Heyco® for molded and stamped products.
PennEngineering’s steadfast commitment to engineering expertise and global innovation ensures that we continue to grow our portfolio with technologies and solutions that allow our customers to not only keep pace with marketplace challenges – but exceed them.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240722804353/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kaneka Expands Global Reach with i-ED COIL™ Launch in Europe10.11.2025 03:51:00 CET | Press release
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) has begun sales of its i-ED COIL™, a brain aneurysm embolization coil (*1), in Europe as of October. The product obtained EC certification (*2) under an EU Medical Device Regulation (*3) in July and will be distributed primarily in Europe through Kaneka Medical Europe N.V. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251109744229/en/ i-ED Coil The i-ED COIL™ provides world-class flexibility, enabled by its specialized wire thickness and structural features. This flexibility enables coils to be packed more densely within aneurysms than conventional products and allows treatment of aneurysms with irregular shapes. Its role in reducing the risk of aneurysm rupture is highly regarded by physicians, and since its launch in the Japanese market in 2019, sales have continued to grow steadily. Kaneka is expanding its business in a wide range
Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week8.11.2025 23:15:00 CET | Press release
- 48-week data show a 64% decrease from baseline in proteinuria in IgA nephropathy, 82% decrease from baseline in proteinuria in primary membranous nephropathy, and stabilization of estimated glomerular filtration rate across both diseases - - Vertex on track to initiate rolling submission of Biologics License Application for potential accelerated approval to the U.S. Food and Drug Administration this year; full enrollment completed for Phase 3 RAINIER trial in IgA nephropathy - - Povetacicept in primary membranous nephropathy granted Fast Track Designation by the U.S. Food and Drug Administration and Phase 2/3 pivotal trial initiated - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced updated data for povetacicept (pove) in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) from the ongoing RUBY-3 trial at the American Society of Nephrology (ASN) Kidney Week 2025 in Houston, Texas. Pove is an investigational recombinant fusion protein therapeutic and dual
Westinghouse and Hungary Establish Landmark Nuclear Fuel Partnership8.11.2025 15:00:00 CET | Press release
First Contract Signed with MVM Group to Deliver VVER-440 Fuel to Paks Nuclear Power Plant Westinghouse Electric Company and MVM Group signed a contract to ensure diversification of fuel supply in Hungary. This partnership brings to Paks Nuclear Power Plant (NPP) reliable supply with Westinghouse VVER fuel, manufactured in Europe. The Westinghouse VVER-440 fuel reload deliveries will start in 2028, subject to licensing activities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251107682814/en/ Westinghouse Nuclear Fuel Senior Vice President Aziz Dag, left, and Károly Mátrai, CEO of the MVM Group, signed the Paks VVER-440 contract, Nov. 7, 2025. “Our agreement with Westinghouse is a clear response to today's energy challenges and further strengthens the role of Hungary's leading base power plant in the domestic energy supply. This strategically important step will make the operation of Paks Nuclear Power Plant safer and more f
OMRON Releases the “Medium-Term Roadmap SF 2nd Stage”8.11.2025 07:00:00 CET | Press release
OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November 7, 2025 (JST). This Roadmap presents the Group’s vision and growth strategies through 2030, which are disclosed on our corporate website. Overview of the “Medium-Term Roadmap SF 2nd Stage” Since April 2024, OMRON has been implementing a Structural Reform Program “NEXT 2025” aimed at rebuilding our foundation for profitability and growth. With the completion of this Program in September 2025, we have shifted into a growth phase and formulated a new Roadmap looking ahead to 2030. This Roadmap identifies Business Portfolio Restructuring as a core strategy. We have defined Thirteen Focus Businesses to drive the Group’s future growth. By accelerating our selection and concentration efforts, we aim to build a “distinctive” business portfolio that maximizes overall Group growth. Furthermore, to maximize the growth potential of our Focus Busines
26th UN Tourism General Assembly kicks off in Riyadh7.11.2025 22:13:00 CET | Press release
UN Tourism marks 50 years of global cooperation as leaders from across the industry gather to shape the future of tourism. His Excellency Ahmed Al Khateeb, Minister of Tourism – “The Kingdom will play an integral part in ensuring one of the world’s most powerful generators of jobs and GDP grows in harmony with the Sustainable Development Goals.” UN Tourism Secretary-General ZurabPololikashvili – “The UN Tourism General Assembly brings together tourism leaders from across the world to set the agenda and build a more innovative and inclusive sector. From Riyadh, we will set the agenda for tourism for the years ahead.” The 26th session of the UN Tourism General Assembly opened today in Riyadh, marking a historic first for the Gulf Cooperation Council (GCC) region and the largest Assembly since UN Tourism was founded 50 years ago. Around 160 delegations from member states including ministers, senior officials, and leaders from across industry and civil society are coming together to celebr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
